Literature DB >> 2452379

Excitatory effect of noradrenaline on pacemaker cells in spinal cord primary cultures.

P Legendre1, B Dupouy, J D Vincent.   

Abstract

Intracellular recordings were made from dissociated fetal mouse spinal cord neurons in primary culture. One particular type of neuron, with a large cell body (40-50 micron) and three to five thick neurites, exhibited rhythmic electrical activity of two different types, consisting of either spontaneous burst discharges or tonic action potential firing. Both types of activity appeared to be triggered by an endogenous membrane potential oscillation. Micropressure application of noradrenaline (10(-5) M in the delivery pipette) onto the surface of such cells evoked, in a dose-dependent manner, an increase in the input resistance with a depolarization of the membrane potential. The response to NA was potential-dependent. The maximum change in input resistance was observed at membrane potential values between -60 mV and -45 mV and the response was suppressed at membrane potentials lower than -80 mV. No modification of the response was observed in the presence of 50 mM of tetraethylammonium. The extrapolated reversal potential, close to -90 mV, was modified by increasing extracellular K+ concentration and unaltered by increasing the intracellular Cl- concentration. The decrease in K+ conductance induced by noradrenaline was Ca2+-dependent and reversibly suppressed by Ba2+ (6 mM) and Cd2+ (0.1 mM). This response to noradrenaline was suppressed in the presence of muscarine (10 microM) suggesting that noradrenaline decreases a K+ conductance related to M current. The noradrenaline evoked increase in input resistance was mediated by activation of an alpha 1 receptor site. Prazosin, an alpha 1 antagonist and phentolamine, an alpha 1 alpha 2 antagonist, reversibly suppressed the response in a competitive manner. Yohimbine, a competitive alpha 2 antagonist, also blocked the response, but in a noncompetitive manner. Clonidine, an alpha 2 agonist, isoprenaline, a beta agonist and L-alprenolol, a beta antagonist, had no effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452379     DOI: 10.1016/0306-4522(88)90358-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells.

Authors:  Maria I Wenner; Garth L Maker; Linda F Dawson; Peter D Drummond; Ian Mullaney
Journal:  Cytotechnology       Date:  2015-09-25       Impact factor: 2.058

2.  Electrophysiological responses to somatostatin of rat hypophysial cells in somatotroph-enriched primary cultures.

Authors:  C Chen; J M Israel; J D Vincent
Journal:  J Physiol       Date:  1989-01       Impact factor: 5.182

3.  Differential responses of lateral and ventrolateral rat periaqueductal grey neurones to noradrenaline in vitro.

Authors:  C W Vaughan; R Bandler; M J Christie
Journal:  J Physiol       Date:  1996-01-15       Impact factor: 5.182

4.  Estradiol modulation of phenylephrine-induced excitatory responses in ventromedial hypothalamic neurons of female rats.

Authors:  Anna W Lee; Andreas Kyrozis; Vivien Chevaleyre; Lee-Ming Kow; Nino Devidze; Qiuyu Zhang; Anne M Etgen; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

5.  Alpha 1-adrenoceptors in rat dorsal raphe neurons: regulation of two potassium conductances.

Authors:  Z Z Pan; T J Grudt; J T Williams
Journal:  J Physiol       Date:  1994-08-01       Impact factor: 5.182

6.  A mechanism for nerve cell excitation by norepinephrine via α-1 adrenoceptors: inhibition of potassium M-current.

Authors:  Alexander K Filippov; David A Brown
Journal:  Cell Mol Neurobiol       Date:  2012-08-08       Impact factor: 5.046

7.  The M-current works in tandem with the persistent sodium current to set the speed of locomotion.

Authors:  Jérémy Verneuil; Cécile Brocard; Virginie Trouplin; Laurent Villard; Julie Peyronnet-Roux; Frédéric Brocard
Journal:  PLoS Biol       Date:  2020-11-13       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.